Table 1.
Basic characteristics of the patients that underwent ERCP under sedation.
| Variables (n = 262) | |
|---|---|
| Age (year) | 68.1 ± 16.0 |
| Gender, n (%) | |
| Male | 135 (51.5) |
| Female | 127 (48.5) |
| BMI (kg/m2) | 23.9 ± 4.4 |
| Comorbidity | |
| HTN, n (%) | 96 (36.6) |
| DM, n (%) | 78 (29.7) |
| CAOD, MI, n (%) | 16 (6.1) |
| CHF, n (%) | 2 (0.8) |
| Cerebral infarction, n (%) | 15 (5.7) |
| Antiplatelet, antithrombotic medication use (yes), n (%) | 40 (15.3) |
| ASA status, n (%) | |
| I | 108 (41.2) |
| II | 56 (21.4) |
| III | 98 (37.4) |
ERCP, endoscopic retrograde cholangiography; BMI, body mass index; HTN, hypertension; DM, diabetes mellitus; CAOD, coronary artery obstructive disease; MI, myocardial infarction; CHF, congestive heart failure; ASA, the American Society of Anesthesiologists.